               SEQUENCE LISTING

<110> Bayer Pharma AG

<120> Novel Compounds

<130> BHC123045-WO

<160> 6

<170> BiSSAP 1.2

<210> 1
<211> 20
<212> DNA
<213> Unknown

<220> 
<221> source
<222> 1..20
<223> /mol_type="unassigned DNA"
      /note="L32 forward primer"
      /organism="Unknown"

<400> 1
aagttcatcc ggcaccagtc                                                20


<210> 2
<211> 21
<212> DNA
<213> Unknown

<220> 
<221> source
<222> 1..21
<223> /mol_type="unassigned DNA"
      /note="L32 revers primer"
      /organism="Unknown"

<400> 2
tggcccttga atcttctacg a                                              21


<210> 3
<211> 22
<212> DNA
<213> Unknown

<220> 
<221> source
<222> 1..22
<223> /mol_type="unassigned DNA"
      /note="L32 probe"
      /organism="Unknown"

<400> 3
cccagaggca ttgacaacag gg                                             22


<210> 4
<211> 20
<212> DNA
<213> Unknown

<220> 
<221> source
<222> 1..20
<223> /mol_type="unassigned DNA"
      /note="AXIN2 forward primer"
      /organism="Unknown"

<400> 4
aggccagtga gttggttgtc                                                20


<210> 5
<211> 20
<212> DNA
<213> Unknown

<220> 
<221> source
<222> 1..20
<223> /mol_type="unassigned DNA"
      /note="AXIN2 revers primer"
      /organism="Unknown"

<400> 5
agctctgagc cttcagcatc                                                20


<210> 6
<211> 25
<212> DNA
<213> Unknown

<220> 
<221> source
<222> 1..25
<223> /mol_type="unassigned DNA"
      /note="AXIN2 probe"
      /organism="Unknown"

<400> 6
tctgtgggga agaaattcca taccg                                          25


